Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
ISMP Warns That Some Oral Medications Are Accidentally Given Intravenously August 18, 2015 Irvin Jackson Add Your Comments An alert issued by the Institute for Safe Medication Practices (ISMP) warns about the risk of human error playing a role in hospital medication mistakes, where oral liquid drugs were accidentally given to patients intravenously. The ISMP Medication Safety Alert was issued on August 13, highlighting two recent cases where nurses got confused and injected patients with the antidepressant lorazepam in one case, and chlorhexidine mouthwash in the other. The group says the incidents highlight a need for medical providers to be more alert about the possibility of human error, the need for better drug labeling, and for hospitals to ensure all the appropriate equipment is on hand and ready for nursing staff. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the incident involving lorazepam, sold in the U.S. under the brand name Ativan, the patient could not swallow tablets and had been prescribed a liquid oral dose. The nurse retrieved the dose from an automated dispensing cabinet with an oral syringe. However, she saw the controlled substance schedule IV (C-IV) designation on the label and thought the IV stood for “intravenous.” When the oral syringe would not fit the IV access port, she switched the medication to another syringe that would, not realizing that it did not fit because the drug was not an IV-administered medication. The patient was observed and sent to a rehabilitation procedure after the mistake was discovered. The report does not indicate whether the patient suffered any adverse effects. The second incident involved a patient who was prescribed chlorhexidine mouthwash due to extensive oral surgery. While it was given out by the pharmacy in prepackaged cups, the patient asked the nurse if it could be placed in a syringe so that the patient could self-administer it. The nurse was unable to find an oral syringe, so instead used a parenteral syringe, but did not label it. Later, the nurse returned from other duties to perform a saline flush for the patient’s saline lock, failed to remember she had placed the oral mouthwash in the parenteral syringe and mistook it for the saline flush, injecting it into the patient’s peripheral arm catheter. The patient complained of a stinging sensation and the nurse realized the mistake. The patient suffered local pain overnight but no other apparent adverse effects and was discharged the next day. “These cases reflect the impact of system vulnerabilities, at-risk behaviors, human factors, and technology limitations,” the ISMP warning indicates. “In both cases, the nurses were distracted from the immediate task at hand and lost situational awareness.” The ISMP notes that while some technological devices have been designed to prevent these types of errors, they cannot replace human vigilance and proper preparation. The alert recommended healthcare professionals step back and reassess the situation whenever something appears to be amiss, like an unlabeled syringe, or an IV port not fitting correctly. The ISMP also recommends that distractions and interruptions be as limited as possible, that oral syringes be stocked, easily identified and used, that labeling policies be enforced, and that pharmacy labels be designed clearly and without misleading clues. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Ativan, Medication Error, Pharmaceutical Mistake More Lawsuit Stories Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 December 23, 2025 Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025 Hyundai Seat Collapse Lawsuit Filed Over Severe Spinal Injury in Rear-End Accident December 23, 2025 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 4 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 5 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 4 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 5 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)